MARKER THERAPEUTICS, INC. Loss Contingency, Damages Sought, Value
MARKER THERAPEUTICS, INC. (MRKR) reported Loss Contingency, Damages Sought, Value of $1.60 million for the 6-month period ending 2021-06-30, per its 10-Q filed 2021-08-10.
Discontinued › Notes › Commitment and Contingencies › Loss Contingency
us-gaap:LossContingencyDamagesSoughtValue · last filed 2021-08-10
- MARKER THERAPEUTICS, INC. loss contingency, damages sought, value for the quarter ending 2021-06-30 was $600.00K.
- MARKER THERAPEUTICS, INC. loss contingency, damages sought, value for the quarter ending 2021-03-31 was $1.00M, a 0.00% change year-over-year.
- MARKER THERAPEUTICS, INC. loss contingency, damages sought, value for the quarter ending 2020-12-31 was $0.00.
- MARKER THERAPEUTICS, INC. loss contingency, damages sought, value for the quarter ending 2020-09-30 was $0.00.
- MARKER THERAPEUTICS, INC. loss contingency, damages sought, value for fiscal 2020 was $1.00M, a 0.00% change from fiscal 2019.
- MARKER THERAPEUTICS, INC. loss contingency, damages sought, value for fiscal 2019 was $1.00M.
| Period end | Loss Contingency, Damages Sought, Value 1 month | Loss Contingency, Damages Sought, Value 3 month | Loss Contingency, Damages Sought, Value 6 month | Loss Contingency, Damages Sought, Value 9 month | Loss Contingency, Damages Sought, Value 12 month |
|---|---|---|---|---|---|
| 2021-06-30 | $600.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $1.60M 10-Q · filed 2021-08-10 | $1.60M derived: sum of 3 quarters · filed 2021-08-10 | $1.60M derived: sum of 4 quarters · filed 2021-08-10 | |
| 2021-03-31 | $1.00M 10-Q · filed 2021-05-12 | $1.00M derived: sum of 2 quarters · filed 2021-05-12 | $1.00M derived: sum of 3 quarters · filed 2021-05-12 | $1.00M derived: sum of 4 quarters · filed 2021-05-12 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | $0.00 derived: sum of 2 quarters · filed 2021-03-09 | $0.00 derived: sum of 3 quarters · filed 2021-03-09 | $1.00M 10-K · filed 2021-03-09 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $0.00 derived: sum of 2 quarters · filed 2020-11-09 | $1.00M 10-Q · filed 2020-11-09 | $1.00M derived: sum of 4 quarters · filed 2020-11-09 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $1.00M 10-Q · filed 2020-08-10 | $1.00M derived: sum of 3 quarters · filed 2020-08-10 | $1.00M derived: sum of 4 quarters · filed 2020-08-10 | |
| 2020-03-31 | $1.00M 10-Q · filed 2020-05-11 | $1.00M derived: sum of 2 quarters · filed 2020-05-11 | $1.00M derived: sum of 3 quarters · filed 2020-05-11 | ||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $0.00 derived: sum of 2 quarters · filed 2020-03-12 | $1.00M 10-K · filed 2020-03-12 | ||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $1.00M 10-Q · filed 2019-11-12 | |||
| 2019-06-30 | $1.00M 10-Q · filed 2019-08-09 | ||||
| 2017-06-26 | $57.00K 10-Q · filed 2017-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |